---
layout: minimal-medicine
title: Indium (In 111) Pentetreotide
---

# Indium (In 111) Pentetreotide
### Generic Name
Indium (In 111) Pentetreotide

### Usage
Indium (In 111) pentetreotide is a radiopharmaceutical used in nuclear medicine for imaging neuroendocrine tumors (NETs).  These are tumors that arise from cells that produce hormones.  The primary use is to locate primary and metastatic NETs that express somatostatin receptors on their surfaces.  This helps doctors determine the size, location, and extent of the tumor spread.  While it can be used to detect various NETs, it's important to remember that newer, more sensitive imaging agents like those using Gallium-68 are often preferred due to lower radiation exposure.


### Dosage

**Neuroendocrine Tumor Imaging (Adults):**

* **Planar imaging:** 3 mCi (111 MBq) administered intravenously (IV).
* **Single-photon emission computed tomography (SPECT) imaging:** 6 mCi (222 MBq) administered IV.

**Neuroendocrine Tumor Imaging (Pediatric):**

* 0.14 mCi/kg (5 MBq/kg) administered intravenously (IV).  The exact dose will depend on the child's weight.

**Dosage Adjustments:** The manufacturer's labeling does not specify dosage adjustments for hepatic (liver) or renal (kidney) impairment. However, caution is advised in patients with renal impairment.


### Side Effects

Common side effects are not explicitly defined in the provided information, however allergic or idiosyncratic reactions are possible.


Serious but less common side effects are also not specified in the available information.  However,  it is crucial to report *any* unusual symptoms to a healthcare professional immediately.


### How it Works

Indium (In 111) pentetreotide is a radiolabeled somatostatin analog.  Somatostatin is a hormone that regulates various bodily functions. Many NETs have a high density of receptors for somatostatin on their surfaces.  The indium-111 pentetreotide binds to these receptors. After the radiopharmaceutical is injected intravenously, it travels through the bloodstream. Areas with a high concentration of somatostatin receptors (meaning areas with NETs) will accumulate the radiotracer.  This accumulation is then detected using a specialized camera (gamma camera) to create images that reveal the location and size of the tumors.


### Precautions

* **Pregnancy and Lactation:**  Indium (In 111) pentetreotide is categorized as pregnancy category C.  This means that potential risks to a developing fetus are not fully understood. Use during pregnancy only if clearly needed and potential benefits outweigh the risks. Breastfeeding may need to be interrupted due to potential radiation exposure to the infant.
* **Renal Impairment:** Use with caution in patients with kidney problems.
* **Concurrent Medications:** The sensitivity of the scan may be reduced if the patient is taking octreotide.  Discuss this with your doctor before the procedure.
* **General Precautions:** The preparation is for intravenous administration only and should not be mixed with other solutions or administered through the same line as other fluids. Patients should be well-hydrated before and after the procedure.  Laxatives may be used to help minimize radiation exposure to the bladder.  Appropriate safety measures should be followed for handling and disposal of the radiopharmaceutical to minimize radiation exposure for healthcare workers.


### FAQs

* **Q: How long does the imaging procedure take?**  A: The imaging time itself varies, depending on the type of imaging done (planar or SPECT).  However, the overall process including preparation and injection will likely take several hours.

* **Q: What should I expect after the injection?** A: You may be asked to increase fluid intake and void frequently to help flush the radiotracer out of your system.  You may experience some minor discomfort at the injection site.  Report any unusual symptoms immediately to your doctor.

* **Q: Are there any long-term side effects?** A: Long-term side effects are rare but possible due to radiation exposure. Your doctor will discuss any potential long-term risks with you before the procedure.

* **Q: How is the medication stored?** A:  Indium (In 111) pentetreotide is a radiopharmaceutical and its storage is handled by healthcare professionals in accordance with radiation safety regulations.  Do not attempt to store or handle it yourself.

* **Q: Is this the best imaging technique for all NETs?**  A:  While effective for many NETs, newer techniques using other radiotracers such as gallium Ga 68 dotatate are often favored due to improved sensitivity and lower radiation dose. Your doctor will determine the most appropriate imaging method for your specific situation.


**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice. Always consult with a healthcare professional before starting any treatment or making any changes to your medical care.  The information provided here is based on the data supplied and may not be fully comprehensive.  Always refer to the official prescribing information for complete and up-to-date details.
